YOQNEAM, Israel, Sept. 23, 2013 (GLOBE NEWSWIRE) -- Given Imaging Ltd, (Nasdaq:GIVN), a world leader in gastrointestinal medical devices and pioneer of capsule endoscopy, today announced that Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval for the PillCam SB 3 system. The innovative technology in this third-generation system will provide physicians throughout Japan, the world's second largest healthcare market, with the most advanced PillCam capsule endoscopy technology to detect and monitor small bowel diseases, such as Crohn's disease.
Videos accompanying this release are available athttp://www.globenewswire.com/newsroom/prs/?pkgid=21089http://www.globenewswire.com/newsroom/prs/?pkgid=20409
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=20408
"Approval of the PillCam SB 3 system in Japan
underscores our global commitment to providing physicians with innovative tools to detect and monitor abnormalities of the gastrointestinal tract," said Homi Shamir
, President and CEO, Given Imaging
. "The approval of the PillCam SB 3 system in Japan
builds upon our recent regulatory momentum that includes PillCam COLON in Japan
and PillCam SB 3 in the U.S. Japan
is a critically important healthcare market and we look forward to working with physicians there to integrate PillCam SB 3's benefits into clinical practice."